KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes

International Journal of Oncology

Volumn 29, Issue 4, 2006, Pages 851-859

  Bellone, Graziella ^a   Smirne, Carlo ^a   Carbone, Anna ^b   Buffolino, Alessandra ^a   Scirelli, Tiziana ^a   Prati, Adriana ^a   Solerio, Dino ^a   Pirisi, Mario ^c   Valente, Guido ^c   Nano, Mario ^a   Emanuelli, Giorgio ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Adenoma; c kit; Colon carcinoma; Imatinib mesylate; Stem cell factor; Tyrosine inhibitors

Indexed keywords

MESSENGER RNA; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CHEMISTRY; COLON TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELL FACTOR;

EID: 34250814096     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.4.851     Document Type: Article

References (63)

1. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
2. Kinzler KW and Vogelstein B: Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761-763, 1997.
3. Cho KR and Vogelstein B: Genetic alterations in the adenoma-carcinoma sequence. Cancer 70: 1727-1731, 1992.
4. Eshleman JR and Markowitz SD: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 7: 83-89, 1995.
5. Marra G and Boland CR: Hereditary non-polyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87: 1114-1125, 1995.
6. Kolodner R: Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev 10: 1433-1442, 1996.
7. Myohanen SK, Baylin SB and Herman JG: Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 58: 591-593, 1998.
8. Yorke R, Chirala M and Younes M: c-kit proto-oncogene product is rarely detected in colorectal adenocarcinoma. J Clin Oncol 21: 3885-3886, 2003.
9. Reed J, Ouban A, Schickor FK, Muraca P, Yeatman T and Coppola D: Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma. Clin Colorectal Cancer 2: 119-122, 2002.
10. Sammarco I, Capurso G, Coppola L, et al: Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients. Int J Colorectal Dis 19: 545-553, 2004. (Pubitemid 39445410)
11. Yarden Y, Kuang WJ, Yang-Feng T, et al: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6: 3341-3351, 1987.
12. Besmer P, Murphy JE, George PC, et al: A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320: 415-421, 1986. (Pubitemid 16097805)
13. Anderson DM, Lyman SD, Baird A, et al: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63: 235-243, 1990. (Pubitemid 20359521)
14. Galli SJ, Zsebo KM and Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55: 1-96, 1994. (Pubitemid 2026071)
15. Wang C, Curtis JE, Geissler EN, McCulloch EA and Minden MD: The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. Leukemia 3: 699-702, 1989. (Pubitemid 19233741)
16. Ikeda H, Kanakura Y, Tamaki T, et al: Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78: 2962-2968, 1991.
17. Natali PG, Nicotra, MR, Winkler AB, Cavaliere R, Bigotti A and Ullrich A: Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 52: 197-201, 1992.
18. Montone KT, van Belle P, Elenitsas R and Elder DE: Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Mod Pathol 10: 939-944, 1997. (Pubitemid 27431970)
19. Berdel WE, De Vos S, Maurer J, et al: Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52: 3498-3502, 1992.
20. Tian Q, Frierson HF Jr, Krystal GW and Moskaluk CA: Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154: 1643-1647, 1999. (Pubitemid 29262845)
21. Bokemeyer C, Kuczyk MA, Dunn T, et al: Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol 122: 301-306, 1996. (Pubitemid 26144858)
22. Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C and Ullrich A: Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer 52: 713-717, 1992.
23. Hines SJ, Organ C, Kornstein MJ and Krystal GW: Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ 6: 769-779, 1995.
24. Hida T, Ueda R, Sekido Y, et al: Ectopic expression of c-kit in small-cell lung cancer. Int J Cancer Suppl 8: 108-109, 1994.
25. Krystal GW, Hines SJ and Organ CP: Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res 56: 370-376, 1996.
26. Feng F, Liu XH, Xie Q, Liu WQ, Bai CG and Ma DL: Expression and mutation of c-kit gene in gastrointestinal stromal tumors. World J Gastroenterol 9: 2548-2451, 2003.
27. Vlahovic G and Crawford J: Activation of tyrosine kinases in cancer. Oncologist 8: 531-538, 2003.
28. Bellone G, Carbone A, Sibona N, et al: Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. Cancer Res 61: 2200-2206, 2001.
29. Attoub S, Rivat C, Rodrigues S, et al: The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. Cancer Res 17: 4879-4883, 2002.
30. Astler VB and Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846-852, 1954.
31. Carbone A, Rodeck U, Mauri FA, et al: Human pancreatic carcinoma cells secrete bioactive Interleukin-18 after treatment with 5-Fluorouracil: implications for anti-tumor immune response. Cancer Biol Ther 4: 231-241, 2005.
32. Ramakers C, Ruijter JM, Deprez RH and Moorman AF: Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62-66, 2003.
33. Rasmussen R: Quantification on the LightCycler. In: Rapid Cycle Real-time PCR, Methods and Applications. Meuer S, Wittwer C and Nakagawara K (eds). Springer Press, Heidelberg, pp21-34, 2001.
34. Pfaffl MW, Horgan GW and Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: E36, 2002.
35. Graadt van Roggen JF, van Velthuysen ML and Hogendoorn PC: The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 54: 96-102, 2001.
36. Kauma S, Huff T, Krystal G, Ryan J, Takacs P and Turner T: The expression of stem cell factor and its receptor, c-kit in human endometrium and placental tissues during pregnancy. Clin Endocrinol Metab 81: 1261-1266, 1996.
37. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987.
38. Bellone G, Silvestri S, Artusio E, et al: Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol 172: 1-11, 1997.
39. Hogendoorn PC, Joensuu H, Le Cesne A, et al: GIST consensus meeting panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16: 566-578, 2005.
40. Miettinen M and Lasota J: KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13: 205-220, 2005. (Pubitemid 41209013)
41. Zhang S, Anderson DF, Bradding P, et al: Human mast cells express stem cell factor. J Pathol 186: 59-66, 1998. (Pubitemid 28407489)
42. Heinrich MC, Dooley DC, Freed AC, et al: Constitutive expression of steel factor gene by human stromal cells. Blood 82: 771-783, 1993. (Pubitemid 23221655)
43. Broudy VC, Kovach NL, Bennett LG, Lin N, Jacobsen FW and Kidd PG: Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83: 2145-2152, 1994.
44. Huang EJ, Nocka KH, Buck J and Besmer P: Differential expression and processing of two cell-associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 3: 349-362, 1992. (Pubitemid 23095970)
45. Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE and Toyama K: Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 85: 641-649, 1995.
46. Russell ES: Hereditary anemias of the mouse: a review for geneticists. Adv Genet 20: 357-459, 1979.
47. Tajima Y, Moore MA, Soares V, Ono M, Kissel H and Besmer P: Consequences of exclusive expression in vivo of Kit-ligand lacking the major proteolytic cleavage site. Proc Natl Acad Sci USA 95: 11903-11908, 1998.
48. Williams DE, De Vries P, Namen AE, Widmer MB and Lyman SD: The Steel factor. Dev Biol 151: 368-376, 1992.
49. McCoshen JA and McCallion DJ: A study of the primordial germ cells during their migratory phase in Steel mutant mice. Experientia 31: 589-590, 1975.
50. Silvers WK: Dominant spotting, patch and rump white. In: The coat colors of mice: a model for gene action and interaction. Springer-Verlag, New York, pp206-332, 1979.
51. Inoue M, Kyo S, Fujita M, Enomoto T and Kondoh G: Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res 54: 3049-3053, 1994.
52. Hibi K, Takahashi T, Sekido Y, et al: Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6: 2291-2296, 1991.
53. Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M and Slamon D: Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153: 511-515, 1995.
54. Toyota M, Hinoda Y, Takaoka A, et al: Expression of c-kit and kit ligand in human colon carcinoma cells. Tumour Biol 14: 295-302, 1993.
55. Lahm H, Amstad P, Yilmaz A, et al: Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 6: 1111-1118, 1995.
56. Bellone G, Ferrero D, Carbone A, et al: Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571. Cancer Biol Ther 3: 385-392, 2004.
57. Krams M, Parwaresch R, Sipos B, Heidorn K, Harms D and Rudolph P: Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis. Oncogene 23: 588-595, 2004.
58. Micke P, Basrai M, Faldum A, et al: Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications. Clin Cancer Res 9: 188-194, 2003.
59. Iqbal S and Lenz HJ: Integration of novel agents in the treatment of colorectal cancer. Cancer Chemother Pharmacol 54 (suppl 1): S32-S39, 2004. (Pubitemid 39517746)
60. Druker BJ: Imatinib as a paradigm of targeted therapies. Adv Cancer Res 91: 1-30, 2004.
61. Sawaki A and Yamao K: Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors. Cancer Chemother Pharmacol 54 (suppl 1): S44-S49, 2004.
62. Demetri GD, von Mehren M, Blanke CD, et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347: 472-480, 2002.
63. Toyota M, Hinoda Y, Itoh F, Takaoka A, Imai K and Yachi A: Complementary DNA cloning and characterization of truncated form of c-kit in human colon carcinoma cells. Cancer Res 54: 272-275, 1994.